Literature DB >> 15774853

12-hour versus 24-hour creatinine clearance in critically ill pediatric patients.

Sandra Pong1, Winnie Seto, Mohamed Abdolell, Angela Trope, Karen Wong, Joann Herridge, Elizabeth Harvey, Brian P Kavanagh.   

Abstract

Measurement of renal function is important to optimize drug dosing in critically ill pediatric patients and to prevent dose-related toxicities caused by medications that are eliminated or metabolized by the kidney. In clinical practice, the 24-h creatinine clearance (CrCl) is used as a surrogate marker of renal function. However, a 24-h urine collection period delays the availability of the result and increases the potential for collection errors. This prospective, observational study was performed to determine whether a 12-h CrCl is comparable to the traditional 24-h CrCl and to assess whether CrCl could be reliably predicted by the Schwartz equation, which mathematically estimates a child's GFR. A 24-h urine sample was collected in two 12-h aliquots from 60 catheterized critically ill children (age 2 d to 18 y). CrCl and Schwartz glomerular filtration rate (GFR) estimates were determined for each 12- and 24-h period. Agreement between 12- and 24-h CrCl and between CrCl and Schwartz GFR estimates was assessed using intraclass correlation coefficients (ICCs). An ICC > or =0.8 was considered to indicate excellent agreement. The ICC between the first 12-h CrCl and 24-h CrCl was 0.9605. The ICC between the second 12-h CrCl and 24-h CrCl was 0.9602. The ICC between the 24-h CrCl and Schwartz GFR was only 0.7046. All comparisons of 12- and 24-h CrCl indicated excellent agreement. In summary, the Schwartz equation was not a reliable estimate of renal function in critically ill children, and a 12-h CrCl is just as accurate as the standard 24-h CrCl to assess renal function and guide drug dosing.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15774853     DOI: 10.1203/01.PDR.0000156225.93691.4F

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  7 in total

Review 1.  Augmented renal clearance: implications for antibacterial dosing in the critically ill.

Authors:  Andrew A Udy; Jason A Roberts; Robert J Boots; David L Paterson; Jeffrey Lipman
Journal:  Clin Pharmacokinet       Date:  2010       Impact factor: 6.447

2.  Pharmacokinetics and pharmacodynamics of meropenem in elderly chinese with lower respiratory tract infections: population pharmacokinetics analysis using nonlinear mixed-effects modelling and clinical pharmacodynamics study.

Authors:  Qing-tao Zhou; Bei He; Chao Zhang; Suo-di Zhai; Zhen-ying Liu; Jie Zhang
Journal:  Drugs Aging       Date:  2011-11-01       Impact factor: 3.923

3.  Augmented renal clearance in pediatric intensive care: are we undertreating our sickest patients?

Authors:  Evelyn Dhont; Tatjana Van Der Heggen; Annick De Jaeger; Johan Vande Walle; Peter De Paepe; Pieter A De Cock
Journal:  Pediatr Nephrol       Date:  2018-10-29       Impact factor: 3.714

4.  Augmented renal clearance in Japanese intensive care unit patients: a prospective study.

Authors:  Yasumasa Kawano; Shinichi Morimoto; Yoshito Izutani; Kentaro Muranishi; Hironari Kaneyama; Kota Hoshino; Takeshi Nishida; Hiroyasu Ishikura
Journal:  J Intensive Care       Date:  2016-10-03

5.  Area under the Curve-Based Dosing of Vancomycin in Critically Ill Patients Using 6-Hour Urine Creatinine Clearance Measurement.

Authors:  Bita Shahrami; Farhad Najmeddin; Saeideh Ghaffari; Atabak Najafi; Mohammad Reza Rouini; Mojtaba Mojtahedzadeh
Journal:  Crit Care Res Pract       Date:  2020-12-24

6.  DBnorm as an R package for the comparison and selection of appropriate statistical methods for batch effect correction in metabolomic studies.

Authors:  Nasim Bararpour; Federica Gilardi; Cristian Carmeli; Jonathan Sidibe; Julijana Ivanisevic; Tiziana Caputo; Marc Augsburger; Silke Grabherr; Béatrice Desvergne; Nicolas Guex; Murielle Bochud; Aurelien Thomas
Journal:  Sci Rep       Date:  2021-03-11       Impact factor: 4.379

7.  A Prospective Study to Assess Vancomycin Serum Concentrations inPediatric Patients with Current Dosing Guidelines.

Authors:  Peyman Arfa; Abdollah Karimi; Sedigheh Rafiei Tabatabaei; Alireza Fahimzad; Shahnaz Armin; Mohammad Sistanizad
Journal:  Iran J Pharm Res       Date:  2016       Impact factor: 1.696

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.